Home
TOP INDUSTRY NEWS
-
Lilly Announces Mfg Expansions in Ireland Totaling $1.8 Bn
-
Roche Opens New $1.4-Bn R&D Center
-
Sanofi Completes Construction of New $554-M Vaccine & Biomedicine Facility
-
Supplier News: PanTera, MilliporeSigma, Evonik & More
-
Pfizer, Moderna Get FDA OK for Updated COVID Vaccines
-
Endo’s CEO Departs; Names Interim CEO
Features
-
Solid Dosage Products: Tracking the Market
What are key moves and trends by CDMOs/CMOs and suppliers in the oral solid-dosage market? A look at key market and technology developments.
-
Reaching the Finish Line: A Big Pharma Outlook
As the industry moves toward the fourth quarter of 2024, what have been the key highlights thus far this year from the bio/pharma majors. Which companies are best positioned to finish strong?
-
SPONSORED CONTENT
OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP
-
SPONSORED CONTENT
Global Scenario: Opportunities and Challenges in Peptides
-
SPONSORED CONTENT
Present And Future of Oncology: What Is Needed from API Suppliers?
DCAT MEMBER COMPANY COMMUNITY
-
Unwind and Network With Us at DCAT After The Show: Milan
Are you gearing up to attend the show in Milan? Join us on Wednesday, October 9th, for an unforgettable and highly anticipated annual networking event, DCAT After the Show! Regarded…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
-
Women Leaders in Pharma Interview: Ilka Noack, Director of Quality Assurance and Regulatory Affairs, ChemCon GmbH
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Ilka Noack, Director of Quality Assurance and Regulatory Affairs at ChemCon GmbH. Read her…
-
Call for Applicants to Serve on the DCAT Board of Directors
The DCAT Leadership Development Committee seeks qualified DCAT Member Company Representatives to serve on its Board of Directors for the 2025 Fiscal Year (November 1, 2024, through October 31, 2025). This…
